Randel has over 25 years’ experience working in health policy, reimbursement, economics, and data analytics for technology companies and providers. At the end of 2012, Randel sold Neocure Group, a consulting data analytics firm she founded in 2006 to Intralign. Intralign is a novel service business specializing in improving hospital efficiencies and costs using Surgical First Assists in orthopedic procedures. Prior to founding and managing those companies, Randel was VP of Global Government Affairs, Reimbursement and Outcomes Planning for Boston Scientific Corporation for 9 years.
Randel served a four-year term as the first industry representative to the Executive Committee of the Medicare Coverage Advisory Committee (MCAC), contributing to the development of national coverage and MCAC process guidelines. Randel continues to serve on the Executive Advisory Board to the Dean of the University of Michigan’s School of Public Health and has held positions on several device and association boards. She currently serves as Secretary on the MassMedic board. She has published widely in the field of health economics and health policy.
Randel has a Master’s degree in Public Health Policy and Administration from the University of Michigan. Prior to her current career, Randel was a practicing dialysis and transplant nurse for 12 years at the University of Michigan Hospital and Northern Michigan Hospital.